240 related articles for article (PubMed ID: 17085017)
1. Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model.
Gibbs JE; Cock HR
Epilepsy Res; 2007 Feb; 73(2):208-12. PubMed ID: 17085017
[TBL] [Abstract][Full Text] [Related]
2. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Gibbs JE; Walker MC; Cock HR
Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
[TBL] [Abstract][Full Text] [Related]
4. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus.
Mazarati AM; Baldwin R; Klitgaard H; Matagne A; Wasterlain CG
Epilepsy Res; 2004 Feb; 58(2-3):167-74. PubMed ID: 15120747
[TBL] [Abstract][Full Text] [Related]
6. Effect of levetiracetam on visual-spatial memory following status epilepticus.
Zhou JL; Zhao Q; Holmes GL
Epilepsy Res; 2007 Jan; 73(1):65-74. PubMed ID: 17029741
[TBL] [Abstract][Full Text] [Related]
7. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
[TBL] [Abstract][Full Text] [Related]
8. Nonconvulsive status epilepticus on treatment with levetiracetam.
Atefy R; Tettenborn B
Epilepsy Behav; 2005 Jun; 6(4):613-6. PubMed ID: 15876554
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam as a treatment option in non-convulsive status epilepticus.
Rupprecht S; Franke K; Fitzek S; Witte OW; Hagemann G
Epilepsy Res; 2007 Mar; 73(3):238-44. PubMed ID: 17161587
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
11. Development of tolerance to levetiracetam in rats with chronic epilepsy.
van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
[TBL] [Abstract][Full Text] [Related]
12. Levetiractam in the treatment of two children with myoclonic status epilepticus.
Haberlandt E; Sigl SB; Scholl-Buergi S; Karall D; Rauchenzauner M; Rostásy K
Eur J Paediatr Neurol; 2009 Nov; 13(6):546-9. PubMed ID: 19010072
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report.
Trabacca A; Profice P; Costanza MC; Gesualdi M; De Rinaldis M
J Child Neurol; 2007 May; 22(5):639-41. PubMed ID: 17690075
[TBL] [Abstract][Full Text] [Related]
14. Determinants of success in the use of oral levetiracetam in status epilepticus.
Rossetti AO; Bromfield EB
Epilepsy Behav; 2006 May; 8(3):651-4. PubMed ID: 16495155
[TBL] [Abstract][Full Text] [Related]
15. Two years of experience in the treatment of status epilepticus with intravenous levetiracetam.
Eue S; Grumbt M; Müller M; Schulze A
Epilepsy Behav; 2009 Aug; 15(4):467-9. PubMed ID: 19616482
[TBL] [Abstract][Full Text] [Related]
16. Levetiracetam in children with refractory status epilepticus.
Gallentine WB; Hunnicutt AS; Husain AM
Epilepsy Behav; 2009 Jan; 14(1):215-8. PubMed ID: 18926926
[TBL] [Abstract][Full Text] [Related]
17. The use of levetiracetam in a child with nonconvulsive status epilepticus.
Alehan F; Ozcay F; Haberal M
J Child Neurol; 2008 Mar; 23(3):331-3. PubMed ID: 18192652
[TBL] [Abstract][Full Text] [Related]
18. Synergism between topiramate and budipine in refractory status epilepticus in the rat.
Fisher A; Wang X; Cock HR; Thom M; Patsalos PN; Walker MC
Epilepsia; 2004 Nov; 45(11):1300-7. PubMed ID: 15509230
[TBL] [Abstract][Full Text] [Related]
19. Levetiracetam in nonconvulsive status epilepticus in a child with Angelman syndrome.
Weber P
J Child Neurol; 2010 Mar; 25(3):393-6. PubMed ID: 19605773
[TBL] [Abstract][Full Text] [Related]
20. Termination of absence status epilepticus by low-dose intravenous levetiracetam.
Altenmüller DM; Kühn A; Surges R; Schulze-Bonhage A
Epilepsia; 2008 Jul; 49(7):1289-90. PubMed ID: 18638286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
